J B Muhlestein1,2, D L Lappe1, J L Anderson1,2, J B Muhlestein1,2, D Budge1, H T May1, S T Bennett3,4, T L Bair1, B D Horne1,5. 1. Intermountain Heart Institute, Salt Lake City, UT, USA. 2. University of Utah, Department of Internal Medicine, Salt Lake City, UT, USA. 3. Intermountain Central Laboratory, Intermountain Medical Center, Salt Lake City, UT, USA. 4. Department of Pathology, University of Utah, Salt Lake City, UT, USA. 5. Genetic Epidemiology Division, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Abstract
INTRODUCTION: We examined the predictive ability of red cell distribution width (RDW) and the change in RDW during hospitalization (ΔRDW) for length of stay (LOS) and 30-day outcomes after heart failure (HF) inpatient stay. METHODS: Electronic query of Intermountain Healthcare medical records identified patients (N = 6414) with a primary diagnosis of HF who were discharged between 2004 and 2013, had RDW measured within 24 h after admission, and had RDW tested at least once more during the same hospitalization. ΔRDW was defined as the last RDW within 24 h prior to discharge minus the first RDW. RESULTS: Median LOS by initial RDW quartiles was Q1: 3.0, Q2: 3.1, Q3: 3.7, and Q4: 4.0 days (P-trend<0.001), and by ΔRDW quartiles was Q1: 4.1, Q2: 3.4, Q3: 3.6, and Q4: 4.7 days (P-trend<0.001). Both initial RDW (16.8 ± 2.8% vs. 16.3 ± 2.7%, P < 0.001) and ΔRDW (0.21 ± 1.09% vs. 0.14 ± 1.04%, P = 0.039) predicted 30-day readmission vs. no readmit. For 30-day decedents vs. survivors, initial RDW was 17.3 ± 3.0% vs. 16.3 ± 2.6% (P < 0.001), while ΔRDW was +0.20 ± 1.14% vs. +0.14 ± 1.04% (P = 0.15). CONCLUSIONS: Greater initial RDW and ΔRDW during HF hospitalization were associated with 30-day mortality, longer LOS, and 30-day all-cause readmission, suggesting both ΔRDW and initial RDW may aid in personalizing prognosis and treatment.
INTRODUCTION: We examined the predictive ability of red cell distribution width (RDW) and the change in RDW during hospitalization (ΔRDW) for length of stay (LOS) and 30-day outcomes after heart failure (HF) inpatient stay. METHODS: Electronic query of Intermountain Healthcare medical records identified patients (N = 6414) with a primary diagnosis of HF who were discharged between 2004 and 2013, had RDW measured within 24 h after admission, and had RDW tested at least once more during the same hospitalization. ΔRDW was defined as the last RDW within 24 h prior to discharge minus the first RDW. RESULTS: Median LOS by initial RDW quartiles was Q1: 3.0, Q2: 3.1, Q3: 3.7, and Q4: 4.0 days (P-trend<0.001), and by ΔRDW quartiles was Q1: 4.1, Q2: 3.4, Q3: 3.6, and Q4: 4.7 days (P-trend<0.001). Both initial RDW (16.8 ± 2.8% vs. 16.3 ± 2.7%, P < 0.001) and ΔRDW (0.21 ± 1.09% vs. 0.14 ± 1.04%, P = 0.039) predicted 30-day readmission vs. no readmit. For 30-day decedents vs. survivors, initial RDW was 17.3 ± 3.0% vs. 16.3 ± 2.6% (P < 0.001), while ΔRDW was +0.20 ± 1.14% vs. +0.14 ± 1.04% (P = 0.15). CONCLUSIONS: Greater initial RDW and ΔRDW during HF hospitalization were associated with 30-day mortality, longer LOS, and 30-day all-cause readmission, suggesting both ΔRDW and initial RDW may aid in personalizing prognosis and treatment.
Authors: Roger Hullin; Nicolas Barras; Tamila Abdurashidova; Pierre Monney; Julien Regamey Journal: Intern Emerg Med Date: 2018-12-13 Impact factor: 3.397
Authors: Benjamin D Horne; Joseph B Muhlestein; Sterling T Bennett; Joseph Boone Muhlestein; Kurt R Jensen; Diane Marshall; Tami L Bair; Heidi T May; John F Carlquist; Matthew Hegewald; Stacey Knight; Viet T Le; T Jared Bunch; Donald L Lappé; Jeffrey L Anderson; Kirk U Knowlton Journal: JCI Insight Date: 2018-07-26
Authors: Sadeer G Al-Kindi; Chang H Kim; Stephen R Morris; Michael L Freeman; Nicholas T Funderburg; Benigno Rodriguez; Grace A McComsey; Jarrod E Dalton; Daniel I Simon; Michael M Lederman; Chris T Longenecker; David A Zidar Journal: J Acquir Immune Defic Syndr Date: 2017-03-01 Impact factor: 3.731
Authors: Denitza P Blagev; Dave S Collingridge; Susan Rea; Benjamin D Horne; Valerie G Press; Matthew M Churpek; Kyle A Carey; Richard A Mularski; Siyang Zeng; Mehrdad Arjomandi Journal: Front Med (Lausanne) Date: 2018-06-11
Authors: Gianni Turcato; Gianfranco Cervellin; Antonio Bonora; Danieli Prati; Elisabetta Zorzi; Giorgio Ricci; Gian Luca Salvagno; Antonio Maccagnani; Giuseppe Lippi Journal: J Med Biochem Date: 2018-07-01 Impact factor: 3.402